High-sensitivity C-reactive protein is associated with 24-hour ambulatory blood pressure variability in type 2 diabetes and control subjects

1. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132–40. DOI: 10.1016/S0140-6736(09)61717-710.1016/S0140-6736(09)61717-7Search in Google Scholar

2. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke. 2004;35(7):1625–30. DOI: 10.1161/01.STR.0000130422.89335.8110.1161/01.STR.0000130422.89335.8115155971Search in Google Scholar

3. Hage FG. C-reactive protein and hypertension. J Hum Hypertens. 2014;28(7):410–5. DOI: 10.1038/jhh.2013.11110.1038/jhh.2013.11124226100Search in Google Scholar

4. Benedek T, Jako B, Suciu Z, Benedek I. Correlations between severity of coronary atherosclerosis and persistent elevation of circulating C-reactive protein levels 30 days after an acute myocardial infarction. Rom Rev Lab Med. 2014;22(1):49–61. DOI: 10.2478/rrlm-2014-000510.2478/rrlm-2014-0005Search in Google Scholar

5. Cernea S, Dobreanu M. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem medica. 2013;23(3):266–80. DOI: 10.11613/BM.2013.03310.11613/BM.2013.033390007424266296Search in Google Scholar

6. Jin C, Lu L, Zhang RY, Zhang Q, Ding FH, Chen QJ, et al. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clin Chim Acta. 2009;408(1-2):45–9. DOI: 10.1016/j.cca.2009.07.00310.1016/j.cca.2009.07.00319615354Search in Google Scholar

7. Hung M-J, Hsu K-H, Hu W-S, Chang N-C, Hung M-Y. C-reactive protein for predicting prognosis and its gender-specific associations with diabetes mellitus and hypertension in the development of coronary artery spasm. PLoS One. 2013;8(10):e77655. DOI: 10.1371/journal.pone.007765510.1371/journal.pone.0077655381026324204905Search in Google Scholar

8. McCormack JP, Allan GM. Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice? PLoS Med. Public Library of Science; 2010;7(2):e1000196.10.1371/journal.pmed.1000196281482420126381Search in Google Scholar

9. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006;166(13):1368–73. DOI: 10.1001/archinte.166.13.136810.1001/archinte.166.13.136816832001Search in Google Scholar

10. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631–9. DOI: 10.1056/NEJMoa05537310.1056/NEJMoa05537317182988Search in Google Scholar

11. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood Pressure Variability and Organ Damage in a General Population: Results from the PAMELA Study. Hypertension. 2002;39(2):710–4. DOI: 10.1161/hy0202.10437610.1161/hy0202.10437611882636Search in Google Scholar

12. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens. 2013;27(11):663–70. DOI: 10.1038/jhh.2013.4510.1038/jhh.2013.4523739158Search in Google Scholar

13. Musini VM, Wright JM. Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials. PLoS One. 2009;4(5):e5673. DOI: 10.1371/journal.pone.000567310.1371/journal.pone.0005673268256619479061Search in Google Scholar

14. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5(1):93–8. DOI: 10.1097/00004872-198702000-0001310.1097/00004872-198702000-000133584967Search in Google Scholar

15. Kim K-I, Lee J-H, Chang H-J, Cho Y-S, Youn T-J, Chung W-Y, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72(2):293–8. DOI: 10.1253/circj.72.29310.1253/circj.72.29318219169Search in Google Scholar

16. Abramson JL, Lewis C, Murrah NV, Anderson GT, Vaccarino V. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol. 2006;98(5):649–52. DOI: 10.1016/j.amjcard.2006.03.04510.1016/j.amjcard.2006.03.045179097616923454Search in Google Scholar

16. Veerabhadrappa P, Diaz KM, Feairheller DL, Sturgeon KM, Williamson S, Crabbe DL, et al. Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study. J Am Soc Hypertens. 2010;4(4):187–95. DOI: 10.1016/j.jash.2010.04.00510.1016/j.jash.2010.04.005294590820885987Search in Google Scholar

18. Pierdomenico SD, Di Nicola M, Esposito AL, Di Mascio R, Ballone E, Lapenna D, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens. 2009;22(8):842–7. DOI: 10.1038/ajh.2009.10310.1038/ajh.2009.10319498342Search in Google Scholar

19. Tatasciore A, Zimarin M, Rendai G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res. 2008;31(12):2137–46. DOI: 10.1291/hypres.31.213710.1291/hypres.31.213719139603Search in Google Scholar

20. American Diabetes Association. (2) Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38(1):S8–16.10.2337/dc15-S00525537714Search in Google Scholar

21. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. DOI: 10.1093/eurheartj/eht15110.1093/eurheartj/eht15123771844Search in Google Scholar

22. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716. DOI: 10.1161/01.CIR.0000154900.76284.F610.1161/01.CIR.0000154900.76284.F615699287Search in Google Scholar

23. American Diabetes Association. (8) Cardiovascular Disease and Risk Management. Diabetes Care. 2015;38(1):S49–51.10.2337/dc15-S01125537708Search in Google Scholar

24. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143–55. DOI: 10.1038/nrcardio.2013.110.1038/nrcardio.2013.123399972Search in Google Scholar

25. Mena L, Pintos S, Queipo N V, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11. DOI: 10.1097/01.hjh.0000160205.81652.5a10.1097/01.hjh.0000160205.81652.5a15716690Search in Google Scholar

26. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11(10):1133–7. DOI: 10.1097/00004872-199310000-0001910.1097/00004872-199310000-000198258679Search in Google Scholar

27. Parati G, Bilo G, Vettorello M, Groppelli A, Maronati A, Tortorici E, et al. Assessment of overall blood pressure variability and its different components. Blood Press Monit. 2003;8(4):155–9. DOI: 10.1097/00126097-200308000-0000510.1097/00126097-200308000-0000514517478Search in Google Scholar

28. Pearson TA. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. DOI: 10.1161/01.CIR.0000052939.59093.4510.1161/01.CIR.0000052939.59093.4512551878Search in Google Scholar

29. Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, et al. 2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Clin Investig Arterioscler. 2013;25(2):74-82. DOI: 10.1016/j.arteri.2013.03.00210.1016/j.arteri.2013.03.00223849214Search in Google Scholar

30. Ciobanu DM, Veresiu IA, Bala CG, Roman G, Mircea PA. Benefits of bedtime hypertension medication in type 2 diabetes demonstrated on ambulatory blood pressure monitoring. In: Proceedings of the 49th Annual Scientific Meeting of the European Society for Clinical Investigation. Edited by Dumitrascu DL, Portincasa P. Medimond, Italy. 2015:107–12.Search in Google Scholar